Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DHFR | P00374 | 2/20 | 0.80 |
| ▸ | LMNA | P02545 | 1/20 | 0.62 |
| ▸ | MTHFD1 | P11586 | 3/20 | 0.58 |
| ▸ | SOST | Q9BQB4 | 1/20 | 0.57 |
| ▸ | MTHFD2 | P13995 | 3/20 | 0.51 |
| ▸ | FPGS | Q05932 | 2/20 | 0.51 |
| ▸ | ATIC | P31939 | 2/20 | 0.51 |
| ▸ | TYMS | P04818 | 2/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.48 |
| ▸ | MEN1 | O00255 | 1/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.48 |
| ▸ | POLB | P06746 | 1/20 | 0.48 |
| ▸ | GAA | P10253 | 1/20 | 0.48 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.48 |
| ▸ | HPGD | P15428 | 1/20 | 0.48 |
| ▸ | TSHR | P16473 | 1/20 | 0.48 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.48 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.48 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Leucovorin SCHEMBL5132046 | 1.00 | DHFR (0.80) | DHFRLMNAMTHFD1SOSTMTHFD2 | |
| Folinic Acid SCHEMBL29369091 | 1.00 | DHFR (0.80) | DHFRLMNAMTHFD1SOSTMTHFD2 | |
| Leucovorin SCHEMBL21632556 | 1.00 | DHFR (0.80) | DHFRLMNAMTHFD1SOSTMTHFD2 | |
| Leucovorin SCHEMBL4708750 | 1.00 | DHFR (0.80) | DHFRLMNAMTHFD1SOSTMTHFD2 | |
| Leucovorin SCHEMBL8349 | 1.00 | DHFR (0.80) | DHFRLMNAMTHFD1SOSTMTHFD2 | |
| Leucovorin SCHEMBL8350 | 1.00 | DHFR (0.80) | DHFRLMNAMTHFD1SOSTMTHFD2 | |
| Levoleucovorin SCHEMBL571901 | 1.00 | DHFR (0.80) | DHFRLMNAMTHFD1SOSTMTHFD2 | |
| Leucovorin SCHEMBL9054117 | 0.99 | DHFR (0.78) | DHFRLMNAMTHFD1SOSTMTHFD2 | |
| Leucovorin SCHEMBL16207660 | 0.99 | DHFR (0.78) | DHFRLMNAMTHFD1SOSTMTHFD2 | |
| Leucovorin SCHEMBL9054183 | 0.99 | DHFR (0.78) | DHFRLMNAMTHFD1SOSTMTHFD2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-105999263-B | Materials and methods for treating or preventing human epidermal growth factor receptor-3 (HER-3) related diseases | 第一三共欧洲有限公司 | 2021-06-29 | — | — | CN | disclosed |
| EP-3670539-A1 | MATERIAL AND METHODS FOR TREATING OR PREVENTING HER-3 ASSOCIATED DISEASES | Daiichi Sankyo Europe GmbH (DE) | 2020-06-24 | — | — | EP | disclosed |
| EP-3351558-B1 | MATERIAL AND METHODS FOR TREATING OR PREVENTING HER-3 ASSOCIATED DISEASES | DAIICHI SANKYO EUROPE GMBH (DE) | 2020-03-11 | — | — | EP | disclosed |
| EP-3351558-A2 | MATERIAL AND METHODS FOR TREATING OR PREVENTING HER-3 ASSOCIATED DISEASES | Daiichi Sankyo Europe GmbH (DE) | 2018-07-25 | — | — | EP | disclosed |
| US-9988462-B2 | Material and methods for treating or preventing HER-3 associated diseases | DAIICHI SANKYO EUROPE GMBH (DE) | 2018-06-05 | — | — | US | disclosed |
| US-20180134805-A1 | MATERIAL AND METHODS FOR TREATING OR PREVENTING HER-3 ASSOCIATED DISEASES | DAIICHI SANKYO EUROPE GMBH (DE) | 2018-05-17 | — | — | US | disclosed |
| US-9803025-B2 | Material and methods for treating or preventing HER-3 associated diseases | AMGEN, INC. (US) | 2017-10-31 | — | — | US | disclosed |
| EP-2896632-B1 | Material and methods for treating or preventing HER-3 associated diseases | DAIICHI SANKYO EUROPE GMBH (DE) | 2017-10-25 | — | — | EP | disclosed |
| EP-2719708-B1 | Material and methods for treating or preventing HER-3 associated diseases | DAIICHI SANKYO EUROPE GMBH (DE) | 2017-10-25 | — | — | EP | disclosed |
| US-20160222126-A1 | MATERIAL AND METHODS FOR TREATING OR PREVENTING HER-3 ASSOCIATED DISEASES | U3 PHARMA GMBH (DE) | 2016-08-04 | — | — | US | disclosed |
| US-9101760-B2 | Material and methods for treating or preventing HER-3 associated diseases | U3 PHARMA GMBH (DE) | 2015-08-11 | — | — | US | disclosed |
| EP-2896632-A2 | Material and methods for treating or preventing HER-3 associated diseases | U3 Pharma GmbH (DE) | 2015-07-22 | — | — | EP | disclosed |
| EP-2719708-A2 | Material and methods for treating or preventing HER-3 associated diseases | U3 Pharma GmbH (DE) | 2014-04-16 | — | — | EP | disclosed |
| US-20140017166-A1 | MATERIAL AND METHODS FOR TREATING OR PREVENTING HER-3 ASSOCIATED DISEASES | AMGEN, INC. (US) | 2014-01-16 | — | — | US | disclosed |
| EP-2601220-A2 | USE OF HER3 BINDING AGENTS IN PROSTATE TREATMENT | U3 Pharma GmbH (DE) | 2013-06-12 | — | — | EP | disclosed |
| EP-2499162-A2 | MATERIAL AND METHODS FOR TREATING OR PREVENTING HER-3 ASSOCIATED DISEASES | U3 Pharma GmbH (DE) | 2012-09-19 | — | — | EP | disclosed |
| US-20120156130-A1 | USE OF HER3 BINDING AGENTS IN PROSTATE TREATMENT | U3 PHARMA GMBH (DE) | 2012-06-21 | — | — | US | disclosed |
| WO-2012018404-A2 | USE OF HER3 BINDING AGENTS IN PROSTATE TREATMENT | U3 PHARMA GMBH (DE) | 2012-02-09 | — | — | WO | disclosed |
| US-20110229406-A1 | Material and methods for treating or preventing HER-3 associated diseases | U3 PHARMA GMBH (DE) | 2011-09-22 | — | — | US | disclosed |
| WO-2011060206-A2 | MATERIAL AND METHODS FOR TREATING OR PREVENTING HER-3 ASSOCIATED DISEASES | U3 PHARMA GMBH (DE) | 2011-05-19 | — | — | WO | disclosed |